122 related articles for article (PubMed ID: 1943481)
21. Formation of mitochondrial phospholipid adducts by nephrotoxic cysteine conjugate metabolites.
Hayden PJ; Welsh CJ; Yang Y; Schaefer WH; Ward AJ; Stevens JL
Chem Res Toxicol; 1992; 5(2):232-7. PubMed ID: 1643252
[TBL] [Abstract][Full Text] [Related]
22. Studies on the mechanism of nephrotoxicity and nephrocarcinogenicity of halogenated alkenes.
Lock EA
Crit Rev Toxicol; 1988; 19(1):23-42. PubMed ID: 3056657
[TBL] [Abstract][Full Text] [Related]
23. Alterations of the renal function in the isolated perfused rat kidney system after in vivo and in vitro application of S-(1,2-dichlorovinyl)-L-cysteine and S-(2,2-dichlorovinyl)-L-cysteine.
Ilinskaja O; Vamvakas S
Arch Toxicol; 1996; 70(3-4):224-9. PubMed ID: 8825681
[TBL] [Abstract][Full Text] [Related]
24. Biosynthesis of toxic glutathione conjugates from halogenated alkenes.
Dekant W
Toxicol Lett; 2003 Sep; 144(1):49-54. PubMed ID: 12919723
[TBL] [Abstract][Full Text] [Related]
25. Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats.
Kharasch ED; Thorning D; Garton K; Hankins DC; Kilty CG
Anesthesiology; 1997 Jan; 86(1):160-71. PubMed ID: 9009951
[TBL] [Abstract][Full Text] [Related]
26. Conjugation and bioactivation of chlorotrifluoroethylene.
Bonhaus DW; Gandolfi AJ
Life Sci; 1981 Dec; 29(23):2399-405. PubMed ID: 7321765
[No Abstract] [Full Text] [Related]
27. Renal processing of glutathione conjugates. Role in nephrotoxicity.
Elfarra AA; Anders MW
Biochem Pharmacol; 1984 Dec; 33(23):3729-32. PubMed ID: 6508831
[No Abstract] [Full Text] [Related]
28. Biotransformation of L-cysteine S-conjugates and N-acetyl-L-cysteine S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human kidney in vitro: interindividual variability in N-acetylation, N-deacetylation, and beta-lyase-catalyzed metabolism.
Gul Altuntas T; Kharasch ED
Drug Metab Dispos; 2002 Feb; 30(2):148-54. PubMed ID: 11792683
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of L-cysteine S-conjugates and N-(trideuteroacetyl)-L-cysteine S-conjugates of four fluoroethylenes in the rat. Role of balance of deacetylation and acetylation in relation to the nephrotoxicity of mercapturic acids.
Commandeur JN; Stijntjes GJ; Wijngaard J; Vermeulen NP
Biochem Pharmacol; 1991 Jun; 42(1):31-8. PubMed ID: 2069595
[TBL] [Abstract][Full Text] [Related]
30. Metabolic activation of the nephrotoxic haloalkene 1,1,2-trichloro-3,3,3-trifluoro-1-propene by glutathione conjugation.
Vamvakas S; Kremling E; Dekant W
Biochem Pharmacol; 1989 Jul; 38(14):2297-304. PubMed ID: 2751695
[TBL] [Abstract][Full Text] [Related]
31. Metabolic activation and detoxication of nephrotoxic cysteine and homocysteine S-conjugates.
Elfarra AA; Lash LH; Anders MW
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2667-71. PubMed ID: 3458225
[TBL] [Abstract][Full Text] [Related]
32. Toxic, halogenated cysteine S-conjugates and targeting of mitochondrial enzymes of energy metabolism.
Cooper AJ; Bruschi SA; Anders MW
Biochem Pharmacol; 2002 Aug; 64(4):553-64. PubMed ID: 12167474
[TBL] [Abstract][Full Text] [Related]
33. Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells.
Lash LH; Anders MW
J Pharmacol Exp Ther; 1989 Feb; 248(2):531-7. PubMed ID: 2918469
[TBL] [Abstract][Full Text] [Related]
34. In vivo and in vitro nephrotoxicity of the cysteine conjugate of hexachlorobutadiene.
Jaffe DR; Hassall CD; Brendel K; Gandolfi AJ
J Toxicol Environ Health; 1983; 11(4-6):857-67. PubMed ID: 6620416
[TBL] [Abstract][Full Text] [Related]
35. Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells.
McGoldrick TA; Lock EA; Rodilla V; Hawksworth GM
Arch Toxicol; 2003 Jul; 77(7):365-70. PubMed ID: 12700887
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase.
Stevens JL; Hatzinger PB; Hayden PJ
Drug Metab Dispos; 1989; 17(3):297-303. PubMed ID: 2568912
[TBL] [Abstract][Full Text] [Related]
37. Assessment of unscheduled DNA synthesis in a cultured line of renal epithelial cells exposed to cysteine S-conjugates of haloalkenes and haloalkanes.
Vamvakas S; Dekant W; Henschler D
Mutat Res; 1989 Apr; 222(4):329-35. PubMed ID: 2704384
[TBL] [Abstract][Full Text] [Related]
38. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats.
Sheffels P; Schroeder JL; Altuntas TG; Liggitt HD; Kharasch ED
Chem Res Toxicol; 2004 Sep; 17(9):1177-89. PubMed ID: 15377151
[TBL] [Abstract][Full Text] [Related]
39. Cytosolic C-S lyase activity in human kidney samples-relevance for the nephrotoxicity of halogenated alkenes in man.
McCarthy RI; Lock EA; Hawksworth GM
Toxicol Ind Health; 1994; 10(1-2):103-12. PubMed ID: 7570611
[TBL] [Abstract][Full Text] [Related]
40. Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene.
Finkelstein MB; Baggs RB; Anders MW
J Pharmacol Exp Ther; 1992 Jun; 261(3):1248-52. PubMed ID: 1602387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]